news, journals and articles from all over the world.
With Lung Cancer Awareness Month upon us, Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s scientists, physician-scientists, and staff
Read moreTwo UC San Diego School of Medicine-led analyses report that e-cigarettes are not effective in helping adults to quit smoking.
Read more
Most pulmonary nodules prove harmless. But in some cases, they can be a sign of lung cancer. Learn how doctors find, test and – if necessary – remove nodules from the lungs.
Read more
A mobile platform for lung cancer screening with low-dose computed tomography (CT) can be developed with limited financial risk and take powerful screening tests directly to patients, including underserved rural areas where rates of new lung cancer cases tend to be higher.
Read moreIn a new study published in Nature Scientific Reports, Moffitt Cancer Center researchers have shown how the use of radiomics can improve lung cancer screening by identifying early stage lung cancer patients who may be at high risk for poorer outcomes, and therefore require aggressive follow-up and/or adjuvant therapy.
Read more
A UK study of patients participating in low-dose CT lung cancer screening highlights the importance of spirometry (breathing tests) in the assessment of possible chronic obstructive pulmonary disease (COPD), and demonstrates that over-reliance on radiological changes alone may result in detection of clinically insignificant disease. The new study is published online in the Annals of the American Thoracic Society.
Read more
Dr. Douglas E. Wood describes the findings from the NELSON Trial and what they mean for policy and program development for lung cancer early detection through CT screening.
Read moreResearchers from The University of Texas MD Anderson Cancer Center have shown that a decision aid delivered through tobacco quitlines effectively reaches a screening-eligible population and results in informed decisions about lung cancer screening.
Read more
WHO: Douglas E. Wood, MD, from the University of Washington in Seattle, is a world-renowned surgeon in thoracic oncology. Dr.
Read moreThe Dutch-Belgian Randomized Lung Cancer Screening Trial, known as the NELSON trial (de Koning et al), published Jan. 29 in NEJM, reconfirms that screening high-risk patients greatly reduces lung cancer deaths. Regulators and physicians should act to ensure access to these lifesaving exams.
Read more